These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 10372695)

  • 21. Treatment of isolated hypogonadotropic hypogonadism effect on bone mineral density and bone turnover.
    Guo CY; Jones TH; Eastell R
    J Clin Endocrinol Metab; 1997 Feb; 82(2):658-65. PubMed ID: 9024272
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is the haematopoietic effect of testosterone mediated by erythropoietin? The results of a clinical trial in older men.
    Maggio M; Snyder PJ; Ceda GP; Milaneschi Y; Luci M; Cattabiani C; Masoni S; Vignali A; Volpi R; Lauretani F; Peachey H; Valenti G; Cappola AR; Longo D; Ferrucci L
    Andrology; 2013 Jan; 1(1):24-8. PubMed ID: 23258626
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhanced transdermal delivery of testosterone across nonscrotal skin produces physiological concentrations of testosterone and its metabolites in hypogonadal men.
    Meikle AW; Mazer NA; Moellmer JF; Stringham JD; Tolman KG; Sanders SW; Odell WD
    J Clin Endocrinol Metab; 1992 Mar; 74(3):623-8. PubMed ID: 1740497
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of testosterone replacement with a nongenital, transdermal system, Androderm, in human immunodeficiency virus-infected men with low testosterone levels.
    Bhasin S; Storer TW; Asbel-Sethi N; Kilbourne A; Hays R; Sinha-Hikim I; Shen R; Arver S; Beall G
    J Clin Endocrinol Metab; 1998 Sep; 83(9):3155-62. PubMed ID: 9745419
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The influence of testosterone replacement therapy on well-being, bone mineral density and lipids in elderly men].
    Rabijewski M; Adamkiewicz M; Zgliczyński S
    Pol Arch Med Wewn; 1998 Sep; 100(3):212-21. PubMed ID: 10335026
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics of a transdermal testosterone system in men with end stage renal disease receiving maintenance hemodialysis and healthy hypogonadal men.
    Singh AB; Norris K; Modi N; Sinha-Hikim I; Shen R; Davidson T; Bhasin S
    J Clin Endocrinol Metab; 2001 Jun; 86(6):2437-45. PubMed ID: 11397836
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Body composition and muscle strength in healthy men receiving testosterone enanthate for contraception.
    Young NR; Baker HW; Liu G; Seeman E
    J Clin Endocrinol Metab; 1993 Oct; 77(4):1028-32. PubMed ID: 8408450
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Androgen supplementation in eugonadal men with osteoporosis-effects of 6 months of treatment on bone mineral density and cardiovascular risk factors.
    Anderson FH; Francis RM; Faulkner K
    Bone; 1996 Feb; 18(2):171-7. PubMed ID: 8833211
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of aromatase inhibition on bone mineral density and bone turnover in older men with low testosterone levels.
    Burnett-Bowie SA; McKay EA; Lee H; Leder BZ
    J Clin Endocrinol Metab; 2009 Dec; 94(12):4785-92. PubMed ID: 19820017
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transdermal testosterone gel improves sexual function, mood, muscle strength, and body composition parameters in hypogonadal men.
    Wang C; Swerdloff RS; Iranmanesh A; Dobs A; Snyder PJ; Cunningham G; Matsumoto AM; Weber T; Berman N;
    J Clin Endocrinol Metab; 2000 Aug; 85(8):2839-53. PubMed ID: 10946892
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Randomized placebo-controlled trial of androgen effects on muscle and bone in men requiring long-term systemic glucocorticoid treatment.
    Crawford BA; Liu PY; Kean MT; Bleasel JF; Handelsman DJ
    J Clin Endocrinol Metab; 2003 Jul; 88(7):3167-76. PubMed ID: 12843161
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Raloxifene to prevent gonadotropin-releasing hormone agonist-induced bone loss in men with prostate cancer: a randomized controlled trial.
    Smith MR; Fallon MA; Lee H; Finkelstein JS
    J Clin Endocrinol Metab; 2004 Aug; 89(8):3841-6. PubMed ID: 15292315
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of aromatase inhibition vs. testosterone in older men with low testosterone: randomized-controlled trial.
    Dias JP; Melvin D; Simonsick EM; Carlson O; Shardell MD; Ferrucci L; Chia CW; Basaria S; Egan JM
    Andrology; 2016 Jan; 4(1):33-40. PubMed ID: 26588809
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of raloxifene hydrochloride on bone mineral density, bone metabolism and serum lipids in Chinese postmenopausal women with osteoporosis: a multi-center, randomized, placebo-controlled clinical trial.
    Liu JL; Zhu HM; Huang QR; Zhang ZL; Li HL; Qin YJ; Zhang Y; Wei DL; Lu JH; Liu H; Chen XP; Liu YJ; Ekangaki A; Zheng YM; Diez-Perez A; Harper K
    Chin Med J (Engl); 2004 Jul; 117(7):1029-35. PubMed ID: 15265377
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of transdermal testosterone treatment on serum lipid and apolipoprotein levels in men more than 65 years of age.
    Snyder PJ; Peachey H; Berlin JA; Rader D; Usher D; Loh L; Hannoush P; Dlewati A; Holmes JH; Santanna J; Strom BL
    Am J Med; 2001 Sep; 111(4):255-60. PubMed ID: 11566454
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Changes in quantitative bone histomorphometry in aging healthy men.
    Clarke BL; Ebeling PR; Jones JD; Wahner HW; O'Fallon WM; Riggs BL; Fitzpatrick LA
    J Clin Endocrinol Metab; 1996 Jun; 81(6):2264-70. PubMed ID: 8964862
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Androgen supplementation in eugonadal men with osteoporosis: effects of six months' treatment on markers of bone formation and resorption.
    Anderson FH; Francis RM; Peaston RT; Wastell HJ
    J Bone Miner Res; 1997 Mar; 12(3):472-8. PubMed ID: 9076591
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Bone density and laboratory parameters of bone metabolism in patients with terminal heart disease].
    Christ E; Linka A; Junga G; Odermatt M; Steinert H; Kiowski W; Schmid C
    Schweiz Med Wochenschr; 1996 Sep; 126(37):1553-9. PubMed ID: 8927958
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bone mineral density in hypogonadal men remains low after long-term testosterone replacement.
    Ishizaka K; Suzuki M; Kageyama Y; Kihara K; Yoshida K
    Asian J Androl; 2002 Jun; 4(2):117-21. PubMed ID: 12085102
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term metreleptin treatment increases bone mineral density and content at the lumbar spine of lean hypoleptinemic women.
    Sienkiewicz E; Magkos F; Aronis KN; Brinkoetter M; Chamberland JP; Chou S; Arampatzi KM; Gao C; Koniaris A; Mantzoros CS
    Metabolism; 2011 Sep; 60(9):1211-21. PubMed ID: 21741057
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.